Lista de obras - Michela Cini - Dominio Público Uruguay

A new rapid bedside assay for D-dimer measurement (Simplify D-dimer) in the diagnostic work-up for deep vein thrombosis

artículo científico publicado en 2003

A new rapid bedside assay for quantitative testing of D-Dimer (Cardiac D-Dimer) in the diagnostic work-up for deep vein thrombosis

artículo científico publicado en 2003

A new warfarin dosing algorithm including VKORC1 3730 G > A polymorphism: comparison with results obtained by other published algorithms

artículo científico publicado en 2012

Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal

article by Cristina Legnani et al published July 2006 in British Journal of Haematology

Additive thrombin inhibition by fast moving heparin and dermatan sulfate explains the anticoagulant effect of sulodexide, a natural mixture of glycosaminoglycans

artículo científico publicado en 2003

Age and gender specific cut-off values to improve the performance of D-dimer assays to predict the risk of venous thromboembolism recurrence

artículo científico publicado en 2011

An in vitro study to investigate the interference of enoxaparin on plasma levels of direct oral factor Xa inhibitors measured by chromogenic assays

scientific article published on 30 January 2019

Comparison of five specific assays for determination of dabigatran plasma concentrations in patients enrolled in the START-Laboratory Register

artículo científico publicado en 2018

Contribution of low density lipoprotein receptor-related protein genotypes to coagulation factor VIII levels in thrombotic women

artículo científico publicado en 2006

D-dimer and factor VIII are independent risk factors for recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis

artículo científico publicado en 2008

D-dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep-vein thrombosis.

artículo científico publicado en 2011

D-dimer for the diagnosis of upper extremity deep and superficial venous thrombosis

artículo científico publicado en 2015

D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis

scholarly article by Benilde Cosmi et al published November 2005 in Thrombosis and Haemostasis

D-dimer use for deep venous thrombosis exclusion in elderly patients: a comparative analysis of three different approaches to establish cut-off values for an assay with results expressed in D-dimer units

article

D-dimer, FVIII and thrombotic burden in the acute phase of deep vein thrombosis in relation to the risk of post-thrombotic syndrome

artículo científico publicado en 2014

DOAC plasma levels measured by chromogenic anti-Xa assays and HPLC-UV in apixaban- and rivaroxaban-treated patients from the START-Register

scientific article published on 10 February 2020

Diagnostic Accuracy of a New d-Dimer Assay (Sclavo Auto d-Dimer) for Exclusion of Deep Vein Thrombosis in Symptomatic Outpatients

artículo científico publicado en 2016

Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence: a post-hoc analysis of the PROLONG study

article

Endothelial activation in patients with superficial vein thrombosis (SVT) of the lower limbs

artículo científico publicado en 2017

Evaluation of a chemiluminescent immunoassay, the HemosIL AcuStar D-Dimer, in outpatients with clinically suspected deep venous thrombosis

artículo científico publicado en 2015

Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia

artículo científico publicado en 2010

G20210A prothrombin mutation and critical limb ischaemia in patients with peripheral arterial disease

artículo científico publicado en 2009

Influence of low-density lipoprotein (LDL) receptor-related protein and ABO blood group genotypes on factor XI levels

artículo científico publicado en 2008

Influence of proband's characteristics on the risk for venous thromboembolism in relatives with factor V Leiden or prothrombin G20210A polymorphisms.

artículo científico publicado en 2013

Inherited and acquired thrombophilic alterations in patients with superficial vein thrombosis of lower limbs

scientific article published on 06 February 2014

Measurement of factor XIII (FXIII) activity by an automatic ammonia release assay using iodoacetamide blank-procedure: no more overestimation in the low activity range and better detection of severe FXIII deficiencies

artículo científico publicado en 2015

Multicenter evaluation of a new quantitative highly sensitive D-dimer assay, the Hemosil D-dimer HS 500, in patients with clinically suspected venous thromboembolism

artículo científico publicado en 2009

No early signs of atherosclerotic alterations in carriers of inherited thrombophilia

artículo científico publicado en 2010

Oral contraceptive use in women with poor anticoagulant response to activated protein C but not carrying the factor V Leiden mutation increases the risk of venous thrombosis

artículo científico publicado en 2004

Pharmacodynamics of low molecular weight heparin in patients undergoing bariatric surgery: a prospective, randomised study comparing two doses of parnaparin (BAFLUX study).

artículo científico publicado en 2009

Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long-term recurrence.

artículo científico publicado en 2005

Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study.

artículo científico publicado en 2016

Rivaroxaban in the Treatment of Heparin-Induced Thrombocytopenia.

artículo científico publicado en 2015

Thalidomide-dexamethasone as up-front therapy for patients with newly diagnosed multiple myeloma: thrombophilic alterations, thrombotic complications, and thromboprophylaxis with low-dose warfarin

artículo científico publicado en 2010

The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis.

artículo científico publicado en 2012

The Wells rule and D-dimer for the diagnosis of isolated distal deep vein thrombosis.

artículo científico publicado en 2012

The influence of VKORC1 3730 G > A polymorphism on warfarin dose: reply

artículo científico publicado en 2012

The role of D-dimer and residual venous obstruction in recurrence of venous thromboembolism after anticoagulation withdrawal in cancer patients

artículo científico publicado en 2005

Thrombin generation and intracranial atherosclerotic disease in patients with a transient ischaemic attack.

artículo científico publicado en 2017

Thrombophilic risk factors and peripheral arterial disease severity.

artículo científico publicado en 2010

Variability of cut-off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study.

artículo científico publicado en 2017

Lista de obras de Michela Cini

A new rapid bedside assay for D-dimer measurement (Simplify D-dimer) in the diagnostic work-up for deep vein thrombosis

A new rapid bedside assay for quantitative testing of D-Dimer (Cardiac D-Dimer) in the diagnostic work-up for deep vein thrombosis

A new warfarin dosing algorithm including VKORC1 3730 G > A polymorphism: comparison with results obtained by other published algorithms

Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal

Additive thrombin inhibition by fast moving heparin and dermatan sulfate explains the anticoagulant effect of sulodexide, a natural mixture of glycosaminoglycans

Age and gender specific cut-off values to improve the performance of D-dimer assays to predict the risk of venous thromboembolism recurrence

An in vitro study to investigate the interference of enoxaparin on plasma levels of direct oral factor Xa inhibitors measured by chromogenic assays

Comparison of five specific assays for determination of dabigatran plasma concentrations in patients enrolled in the START-Laboratory Register

Contribution of low density lipoprotein receptor-related protein genotypes to coagulation factor VIII levels in thrombotic women

D-dimer and factor VIII are independent risk factors for recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis

D-dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep-vein thrombosis.

D-dimer for the diagnosis of upper extremity deep and superficial venous thrombosis

D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis

D-dimer use for deep venous thrombosis exclusion in elderly patients: a comparative analysis of three different approaches to establish cut-off values for an assay with results expressed in D-dimer units

D-dimer, FVIII and thrombotic burden in the acute phase of deep vein thrombosis in relation to the risk of post-thrombotic syndrome

DOAC plasma levels measured by chromogenic anti-Xa assays and HPLC-UV in apixaban- and rivaroxaban-treated patients from the START-Register

Diagnostic Accuracy of a New d-Dimer Assay (Sclavo Auto d-Dimer) for Exclusion of Deep Vein Thrombosis in Symptomatic Outpatients

Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence: a post-hoc analysis of the PROLONG study

Endothelial activation in patients with superficial vein thrombosis (SVT) of the lower limbs

Evaluation of a chemiluminescent immunoassay, the HemosIL AcuStar D-Dimer, in outpatients with clinically suspected deep venous thrombosis

Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia

G20210A prothrombin mutation and critical limb ischaemia in patients with peripheral arterial disease

Influence of low-density lipoprotein (LDL) receptor-related protein and ABO blood group genotypes on factor XI levels

Influence of proband's characteristics on the risk for venous thromboembolism in relatives with factor V Leiden or prothrombin G20210A polymorphisms.

Inherited and acquired thrombophilic alterations in patients with superficial vein thrombosis of lower limbs

Measurement of factor XIII (FXIII) activity by an automatic ammonia release assay using iodoacetamide blank-procedure: no more overestimation in the low activity range and better detection of severe FXIII deficiencies

Multicenter evaluation of a new quantitative highly sensitive D-dimer assay, the Hemosil D-dimer HS 500, in patients with clinically suspected venous thromboembolism

No early signs of atherosclerotic alterations in carriers of inherited thrombophilia

Oral contraceptive use in women with poor anticoagulant response to activated protein C but not carrying the factor V Leiden mutation increases the risk of venous thrombosis

Pharmacodynamics of low molecular weight heparin in patients undergoing bariatric surgery: a prospective, randomised study comparing two doses of parnaparin (BAFLUX study).

Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long-term recurrence.

Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study.

Rivaroxaban in the Treatment of Heparin-Induced Thrombocytopenia.

Thalidomide-dexamethasone as up-front therapy for patients with newly diagnosed multiple myeloma: thrombophilic alterations, thrombotic complications, and thromboprophylaxis with low-dose warfarin

The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis.

The Wells rule and D-dimer for the diagnosis of isolated distal deep vein thrombosis.

The influence of VKORC1 3730 G > A polymorphism on warfarin dose: reply

The role of D-dimer and residual venous obstruction in recurrence of venous thromboembolism after anticoagulation withdrawal in cancer patients

Thrombin generation and intracranial atherosclerotic disease in patients with a transient ischaemic attack.

Thrombophilic risk factors and peripheral arterial disease severity.

Variability of cut-off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study.